Read the latest news from Northwestern University Feinberg School of Medicine’s Center for Translational Metabolism and Health. The links below take you to articles where you can learn more about our members' latest achievements, awards and honors.
Co-director of NUGoKidney's Therapeutic Design & Development Core - Pinelopi Kapitsinou, MD - talks about her work examining the molecular mechanisms by which hypoxic signaling modulates responses to acute kidney injury and how findings in the lab translate to novel diagnostic and therapeutic approaches.
Tamara Isakova, MD, MMSc, director of NUGoKidney's Clinical & Translational Core and the Margaret Gray Morton Professor of Medicine, has been named co-director of the Northwestern University Clinical and Translational Sciences (NUCATS) Institute’s KL2 Program, which supports early-career faculty at Northwestern.
Read more about Isakova's vision for the program here.
On November 19, 2020, we lost a treasure of a human being, H. William Schnaper, MD. An exemplary scientist, Bill contributed greatly to the understanding of childhood glomerulonephritis, as well as factors that contribute to renal fibrosis. But Bill’s love for science and medicine didn’t stop at the lab or the clinic. Unceasingly giving and committed, Bill shared his enthusiasm for science and dedication to mentorship in programs he developed for high school and medical students. As director for NUGoKidney’s Enrichment Program, Bill led the creation of the SciHigh Program, which aims to spark students’ curiosity and develop their confidence and skills to achieve success in science and medicine. Personally and professionally, Bill touched the lives of many with his brilliant scientific mind, generous spirit, and compassion for patients - someone so special can never be forgotten.Read Northwestern’s tribute to Bill here.
The Northwestern University Clinical and Translational Sciences (NUCATS) Institute hosted the first virtual COVID-19 symposium, which gave the Northwestern research community an opportunity to learn about efforts to advance public health and respond to the COVID-19 pandemic.
- South Asian Americans face disproportionately higher risks of heart disease, other cardiovascular ailments11.17.2020
- Computer model can predict how COVID-19 spreads in cities11.17.2020
A cell-surface protein is essential for proper microcircuit function in the brain, according to a study published in Nature Communications.
- Jordan Named Director of IPHAM Center for Education in Health Sciences11.10.2020
- The Virginia Bishop Inaugural Youth Leadership Conference: November 7th11.03.2020
- Northwestern Evaluators Present at the Annual Virtual Meeting of the American Evaluation Association11.02.2020
While we'll miss seeing our kidney colleagues and community in-person this year, we're excited to connect with you virtually in this year of reimagination!
We have over 50 presentations, sessions, and posters showcasing research from NUGoKidney and Northwestern researchers.
- Mothers and Babies Program featured in the New York Times10.13.2020
- Mothers and Babies Program Expands Thanks to Perigee Fund09.30.2020
- COVID-19 pandemic should be a wake-up call for water security08.31.2020
- New data shows more Asian American deaths during the COVID pandemic08.31.2020
Certain factors are associated with increased risk of death in critically ill COVID-19 patients, according to recent Northwestern Medicine studies.
Experts from our Therapeutic Design and Development Core were joined by infectious disease and organ transplant expert, Michael Ison, MD, MS and nephrologist and kidney researcher, Anand Srivastava, MD, MPH to discuss about the impact of COVID-19 on the kidneys; recent research efforts; and therapeutic development opportunities.
Gal Finer, MD, PhD, Assistant Professor of Pediatrics in the Division of Kidney Diseases at Lurie Children’s recently received a 5-year K08 award from the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to study the molecular mechanisms underlying congenital anomalies of the kidney and urinary tract, or CAKUT – a common birth defect and the leading cause of chronic kidney disease in children.
We are happy to announce the grants awarded from our recent call for proposals for our FY2021 NUGoKidney Pilot & Feasibility (P&F) Program.
- Webinar Recording Now Available: ACE2 Before and After COVID-19: Basic Concepts with Daniel Batlle, MD07.01.2020What is the link between COVID19 and ACE2? Get the answer in this recording from our June 18, 2020 webinar with Daniel Batlle, MD where he discusses ACE2, the renin angiotensin system, and COVID-19.
Click here to view a recording of the webinar.
2018 NUGoKidney Pilot & Feasibility Grant Awardee - Paul DeCaen, PhD - publishes study uncovering the molecular mechanisms behind the development of autosomal dominant polycystic kidney disease (ADPKD), a common genetic disorder characterized by the growth of numerous cysts in the kidneys.
Read more about the study in FSM News here.
Read the publication in Proceedings of the National Academy of Sciences here.
NUGoKidney Pilot & Feasibility awardee, Anand Srivastava, MD, MPH, recently received a five-year K23 award from the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK). The study aims to examine whether information about kidney blood flow obtained from contrast enhanced ultrasound (CEUS) will help identify patients with chronic kidney disease (CKD) who are at high risk of experiencing progressive loss of kidney function.
On April 29, 2020, NUGoKidney presented the webinar - CRRT for AKI during the COVID-19 Pandemic - with special guest, Ashita Tolwani, MD from the University of Alabama at Birmingham (UAB).
Dr. Tolwani explained how CRRT prescription might need to be adjusted in regards to modality, dose, and anticoagulation for AKI patients with COVID-19.
Click here to view a recording of the webinar.
A new Northwestern Medicine study has shed light on the complex phenomenon of liver zonation, showing that a protein known as Wnt is required for correct placement of tight junction and cell adhesion proteins within the liver.
Studied by Jing Jin, MD, PhD and his team as a therapy for acute kidney injury (AKI) and hypertension, ACE2-fc, was recently included in an article by Robert Kruse, MD, PhD in F100 Research as a potential therapy for COVID-19.
Dr. Jin talks with NM Better Edge podcast about how the ACE2-fc therapy could potentially be used to guard against and treat COVID-19 and highlights the important role of cross collaboration in facilitating discovery. Listen now here.
Over 70 high school juniors from Holy Trinity High School participated in the SciHigh workshop - Data IRL: Thinking Big & Improving Health - focused on real-world uses of data and computing in medicine and health research.
Last year on World Kidney Day, we reached nearly 400,000 people with our #sockittokidneydisease campaign, and we're doing it again this year to amplify the World Kidney Day 2020 message on the importance of preventive interventions to avert the onset and progression of kidney disease.
Ready your socks and learn how you can sock it to kidney disease.
A new study published previously unknown details about the lineage of lymphatic endothelial cells associated with the heart.
Feinberg has had an exceptional year of scientific inquiry, ranging from examining the most basic systems that make our bodies tick to developing breakthrough therapies and treatment strategies.